| 词条 | Draft:Crispr Therapeutics |
| 释义 | {{AFC submission|d|corp|u=Dresdnhope|ns=118|decliner=Chetsford|declinets=20181130014334|ts=20181129173240}} Crispr Therapeutics is a company to develop gene-based medicines based on CRISPR/Cas9 gene editing, co-founded by one of the co-inventors of CRISPR/Cas9, Emmanuelle Charpentier. Crispr Therapeutics is one of the few gene-editing startups that are using the new tool to pursue new treatments for sickle-cell anemia.[1] As of November 2018, the Switzerland-based company had 127 full-time employees.[2] As of October 2018, it was the most valuable CRISPR company stock by market cap.[3] In addition. the company is working on therapies for cystic fibrosis, and beta thalassemia.[4] |
| 随便看 |
|
开放百科全书收录14589846条英语、德语、日语等多语种百科知识，基本涵盖了大多数领域的百科知识，是一部内容自由、开放的电子版国际百科全书。